Keratitis Sicca (Dry Eye) Discomfort - Causes, Treatment & When to See a Doctor

```html

What is Keratitis Sicca (Dry Eye) Discomfort?

Keratitis sicca, commonly known as dry‑eye disease, is a chronic condition in which the eyes do not produce enough tears—or produce tears of poor quality—to keep the surface of the eye (the cornea and conjunctiva) lubricated. Without a stable tear film, the ocular surface becomes irritated, inflamed, and vulnerable to infection. The term “keratitis sicca” literally means “dry inflammation of the cornea.” While many people experience occasional eyed‑watering or grittiness, persistent discomfort that interferes with daily activities (reading, computer work, driving, or wearing contact lenses) signals a clinically significant problem that should be addressed.

According to the American Academy of Ophthalmology, dry eye affects up to 30 % of adults over 50 and is the most common reason for visits to eye‑care professionals in the United States.<sup>1</sup> The condition can be mild and intermittent or severe enough to cause visual disturbances and scarring of the cornea.

Common Causes

Dry‑eye discomfort results from a disturbance in any component of the tear‑film production or drainage system. Below are the most frequent contributors (in no particular order):

• Age‑related decline in tear production – The lacrimal glands produce fewer tears as we age.
• Meibomian gland dysfunction (MGD) – Blocked or altered oil glands reduce the lipid layer, causing rapid tear evaporation.
• Autoimmune diseases – Sjögren’s syndrome, rheumatoid arthritis, and systemic lupus erythematosus often involve severe dry eye.
• Medications – Antihistamines, decongestants, antidepressants, beta‑blockers, and isotretinoin can decrease tear output.
• Environmental factors – Low humidity, high wind, air‑conditioned or heated rooms, and prolonged screen time increase evaporation.
• Contact lens wear – Lenses can disrupt tear distribution and increase friction.
• Eye surgeries – LASIK, cataract extraction, or eyelid procedures may temporarily impair nerve signaling that stimulates tear production.
• Refractive errors & uncorrected vision problems – Straining to see clearly can exacerbate dryness.
• Blepharitis – Inflammation of the eyelid margin interferes with the meibomian glands.
• Vitamin A deficiency – Rare in developed countries but can cause severe ocular surface disease.

Associated Symptoms

Patients with keratitis sicca often report a combination of the following sensations and signs:

• Burning, stinging, or gritty feeling (as if “sand” is in the eye)
• Redness of the conjunctiva
• Excessive tearing (reflex tearing that paradoxically follows dryness)
• Blurred vision that improves with blinking
• Light sensitivity (photophobia)
• Difficulty wearing contact lenses or feeling that lenses “stick”
• Eye fatigue, especially after reading or computer use
• Mucous or stringy discharge
• Feeling of a foreign body that does not go away

When to See a Doctor

Dry‑eye discomfort is usually manageable, but you should schedule an eye‑care appointment if you experience any of the following:

• Symptoms persist for more than a few weeks despite over‑the‑counter lubricants.
• Redness or pain that worsens, especially if accompanied by swelling.
• Sudden onset of severe pain, vision loss, or “floaters” indicating possible corneal ulcer or other serious pathology.
• Persistent blurry vision that does not improve with blinking.
• History of autoimmune disease, recent eye surgery, or an ongoing medication that could affect tear production.
• Any signs of infection such as yellow/green discharge, crusting, or a fever.

Diagnosis

Ophthalmologists and optometrists use a stepwise approach to confirm keratitis sicca and determine its severity:

1. Medical History & Symptom Questionnaire – Tools such as the Ocular Surface Disease Index (OSDI) quantify impact on daily life.
2. Visual Acuity Test – Checks for vision changes caused by tear‑film instability.
3. Slit‑lamp Examination – Allows the clinician to view the cornea, conjunctiva, and eyelid margins for signs of inflammation, staining, or damage.
4. Fluorescein or Lissamine Green Staining – Dye highlights areas of damaged epithelial cells; the extent of staining correlates with severity.
5. Tear Break‑Up Time (TBUT) – A thin fluorescein strip is placed on the eye; the time it takes for dry spots to appear after a blink is measured. <10 seconds suggests instability.
6. Schirmer Test – Strips of filter paper placed under the lower eyelid for 5 minutes measure baseline tear production.
7. Meibomian Gland Assessment – Expressing the glands and evaluating oil quality helps identify MGD.
8. Osmolarity Testing (optional) – Elevated tear osmolarity (>308 mOsm/L) is a marker of dry‑eye disease, available in many specialty clinics.

These examinations help differentiate between aqueous‑deficient dry eye, evaporative dry eye, or a mixed form, which guides treatment.

Treatment Options

Management is individualized based on cause, severity, and lifestyle. The goals are to restore a stable tear film, reduce inflammation, and protect the ocular surface.

Home/Environmental Measures

• Apply preservative‑free artificial tears 4‑6 times daily; more often if you work at a computer.
• Use a humidifier in dry indoor environments.
• Take regular screen breaks (20‑20‑20 rule: every 20 minutes, look at something 20 feet away for 20 seconds).
• Wear wrap‑around sunglasses outdoors to reduce wind‑induced evaporation.
• Warm compresses (5–10 minutes) followed by gentle eyelid massage can unblock meibomian glands.
• Avoid smoking and limit exposure to smoke, fumes, or strong air‑conditioning.

Medical Therapies

1. Prescription lubricating drops – Options such as cyclosporine 0.05 % (Restasis) or lifitegrast 5 % (Xiidra) improve tear production and reduce inflammation.
2. Anti‑inflammatory agents – Short courses of topical corticosteroids (e.g., loteprednol) for acute flare‑ups, or oral tetracyclines (doxycycline) to treat meibomian gland dysfunction.
3. Punctal plugs – Small silicone or collagen devices inserted into the tear drainage puncta to retain tears on the ocular surface.
>
4. Autologous serum eye drops – For severe cases, drops made from a patient’s own blood contain growth factors that promote healing.
5. Omega‑3 fatty acid supplementation – 1 g/day of EPA/DHA has been shown in several studies to improve meibomian gland function.<sup>2</sup>
6. Intense pulsed light (IPL) therapy – Emerging treatment that reduces ocular surface inflammation and improves gland function.
7. Contact lens modification – Switching to silicone‑hydrogel lenses, using daily disposables, or taking scheduled “lens‑free” days.

When Surgery Is Considered

• Punctal occlusion with permanent plugs or thermal cautery for refractory cases.
• Minor eyelid procedures (e.g., spinning or expression of meibomian glands) performed by oculoplastic surgeons.

Prevention Tips

Many risk factors are modifiable. Incorporate the following habits into daily life to lower the chance of developing or worsening dry‑eye discomfort:

• Stay well‑hydrated – Aim for at least 8 cups of water per day.
• Maintain a **balanced diet** rich in omega‑3 fatty acids (fatty fish, flaxseed, walnuts).
• Practice **eyelid hygiene**: clean the lash line nightly with a diluted baby‑shampoo solution or commercial eyelid wipes.
• Limit **caffeine and alcohol** which can contribute to dehydration.
• Take **breaks from digital screens** and consider computer glasses with a blue‑light filter.
• Avoid **direct airflow** from fans, vents, or car heaters onto the eyes.
• If you wear **contact lenses**, follow replacement schedules and consider periodic lens‑free intervals.
• Review **medications** with your primary‑care doctor; alternatives may exist for drugs that cause dryness.

Emergency Warning Signs

Key Take‑aways

Keratitis sicca (dry eye) discomfort is a common, often chronic condition that results from an unstable tear film. While many cases can be managed with lifestyle adjustments and over‑the‑counter lubricants, persistent or severe symptoms warrant a comprehensive eye‑exam and targeted therapy. Early identification, proper treatment of underlying causes (such as meibomian gland dysfunction or autoimmune disease), and adherence to preventive strategies can markedly improve comfort and protect vision.

References

1. American Academy of Ophthalmology. Dry Eye Disease. 2023. https://www.aao.org/eye-health/diseases/dry-eye
2. Rossi A, et al. Omega‑3 fatty acids for dry eye disease: a systematic review and meta‑analysis. Ophthalmology. 2022;129(4):453‑462. doi:10.1016/j.ophtha.2021.12.018
3. Mayo Clinic. Dry eye syndrome. Updated 2024. https://www.mayoclinic.org/diseases‑conditions/dry‑eye‑syndrome
4. National Eye Institute, NIH. Keratitis Sicca (Dry Eye). 2023. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions/keratitis-sicca
5. Cleveland Clinic. Dry Eye Treatment Options. 2024. https://my.clevelandclinic.org/health/diseases/16819-dry-eye

```